Reply to Comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy-induced neutropenia

✍ Scribed by Mark L. Heaney; Edmond L. Toy; Francis Vekeman

• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 63 KB
• Volume: 116
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/cncr.25249